BioGenex RT-PCR Kit detects all Covid variants in half the time
This test analyses samples in VTM directly without the need for RNA extraction step
This test analyses samples in VTM directly without the need for RNA extraction step
New data from ongoing trial showed increased antibody response against Beta, Delta, Alpha, Gamma and Omicron variants following third dose booster with Vaxzevria
The stability is led by healthy demand in the domestic and emerging markets
Four-year research collaboration combines Pfizer’s deep experience in global drug development, including programs utilizing messenger RNA (mRNA), lipid nanoparticles (LNP), and gene therapy, with Beam’s leadership in base editing and mRNA/LNP delivery technologies
In addition to its favourable activity profile, IBIO123 is formulated for administration by inhalation providing an efficient, rapid and non-invasive delivery method into the lungs via the respiratory tract
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma
Topline results from the randomized EMPATHY Part A study in acute Covid-19 ambulatory patients comparing single intravenous doses of ensovibep, a DARPin antiviral therapeutic candidate vs. placebo, met the primary endpoint of viral load reduction over eight days
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
The brand is now available pan-India through their distribution partner
Subscribe To Our Newsletter & Stay Updated